HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glucosone

RN given refers to cpd with unspecified isomeric designation

Also Known As:

2-ketoglucose; D-arabino-2-hexosulose; arabino-hexosulose; glucosone, D isomer

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Sugars: 11126
  - Monosaccharides: 889
    - Ketoses: 19
      - glucosone: 6

Experts

1.	Buchholz, Monika: 1 article (12/2019)
2.	Gerke, Christoph: 1 article (12/2019)
3.	Grimmler, Matthias: 1 article (12/2019)
4.	Metzmann, Erwin: 1 article (12/2019)
5.	Meusinger, Reinhard: 1 article (12/2019)
6.	Müller, Holger: 1 article (12/2019)
7.	Durán-Merás, Isabel: 1 article (10/2012)
8.	Espinosa-Mansilla, Anunciación: 1 article (10/2012)
9.	Hurtado-Sánchez, María del Carmen: 1 article (10/2012)
10.	Martín-Tornero, Elisabet: 1 article (10/2012)

Related Diseases

1.	Neoplasms (Cancer) 03/01/1981 - "Because of a lack of specificity, glucosone is not a suitable inhibitor for studies on the relationship between hexokinase activity and cell proliferation of tumor cells."
2.	Diabetes Mellitus 12/01/2019 - "Direct glucosone-based synthesis and HILIC-ESI-MS/MS characterization of N-terminal fructosylated valine and valylhistidine for validation of enzymatic HbA1c assays in the diagnosis of diabetes mellitus." 08/01/1992 - "Our findings suggest a possible role of lipid peroxidation of low-density lipoproteins (LDL) induced by glucosone in atherosis caused by diabetes mellitus." 10/01/2012 - "The high sensitivity of the method allows the determination of α-dicarbonyl compounds present in human urine, such as D-glucosone, 3-deoxyglucosone, glyoxal, and methylglyoxal, that are used as biomarkers, in order to investigate their roles in several diseases, with special emphasis in diabetes mellitus. "
3.	Ehrlich Tumor Carcinoma 03/01/1981 - "The effect of glucosone on the proliferation and energy metabolism of in vitro grown Ehrlich ascites tumor cells." 01/01/1984 - "A comparative study on proliferation, macromolecular synthesis and energy metabolism of in vitro-grown Ehrlich ascites tumor cells in the presence of glucosone, galactosone and methylglyoxal." 03/01/1981 - "1) Proliferation and energy metabolism of in vitro growth Ehrlich ascites tumor (EAT) cells in the presence of glucosone, (D-arabino-3.4.5.6-tetrahydroxy-2-oxo-hexanal) a competitive inhibitor of hexokinase, were studied. " 01/01/1984 - "Proliferation of in vitro grown Ehrlich ascites tumor cells is completely inhibited by 0.2-0.4 mM methylglyoxal and 1-2 mM glucosone or galactosone without severely affecting viability (dye exclusion test); no phase-specific arrest of cell growth is observed. "
4.	Dehydration (Water Stress) 01/01/1993 - "The analogous D-glucosone dehydration product did not accumulate due to its further transformation. "

Related Drugs and Biologics

1.	Hexokinase
2.	Pyruvaldehyde (Methylglyoxal)
3.	Biomarkers (Surrogate Marker)
4.	Valine (L-Valine)
5.	LDL Lipoproteins (beta Lipoproteins)
6.	Glyoxal (Ethanedial)
7.	Coloring Agents (Dyes)
8.	oxidized low density lipoprotein
9.	galactosone
10.	3-deoxyglucosone